Yuji Miyamoto1, Naoko Hayashi2, Yasuo Sakamoto3, Mayuko Ohuchi3, Ryuma Tokunagam3, Junji Kurashige3, Yukiharu Hiyoshi3, Yoshifumi Baba3, Shiro Iwagami3, Naoya Yoshida3, Megumi Yoshida3, Hideo Baba4. 1. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. miyamotoyuji@gmail.com. 2. Department of Surgery, National Hospital Organization Kumamoto Hospital, 2338 Matsubase, Uki, 869-0593, Japan. 3. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. 4. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. hdobaba@kumamoto-u.ac.jp.
Abstract
BACKGROUND: The prognosis for most patients with stage IV colorectal cancer (CRC) and multi-organ metastases is poor. However, little information is currently available on prognostic factors in these patients. The aim of this study was to identify predictors of a good prognosis in this patient group. METHODS: This was a single-center retrospective study in which we examined the relationship between patient characteristics and prognosis in 161 stage IV CRC patients with indications for first-line systemic chemotherapy. Cox proportional-hazards models were used to compute hazard ratios (HR) for death, adjusted for clinical and pathological characteristics. RESULTS: Of the 161 patients recruited to the study, 83 had single-organ and 78 had multi-organ metastases. Median survival time was significantly shorter in patients with multi-organ metastases than in those with single-organ metastases (19.2 vs. 42.0 months, respectively; log-rank, P < 0.001). There was no significant difference in survival between patients with metastases in two versus three or more organs (log-rank; P = 0.368). According to univariate analysis, primary tumor sites in the left side of the colon and in the rectum, a pretreatment carcinoembryonic antigen concentration of >50 ng/mL, a well-/moderately differentiated tumor, and R0 resection of metastatic lesions were associated with better overall survival. According to multivariate analysis, left-sided location of the primary tumor [HR 0.414, 95 % confidence interval (CI) 0.216-0.815; P = 0.011] and R0 resection of metastatic lesions (HR 0.247, 95 % CI 0.04 0-0.834; P = 0.021) were independently associated with good prognosis. CONCLUSIONS: Our results indicate that the site of the primary tumor in the left side of the colon and in the rectum and R0 resection of metastatic lesions are predictors of a good prognosis in patients with stage IV CRC and multi-organ metastases.
BACKGROUND: The prognosis for most patients with stage IV colorectal cancer (CRC) and multi-organ metastases is poor. However, little information is currently available on prognostic factors in these patients. The aim of this study was to identify predictors of a good prognosis in this patient group. METHODS: This was a single-center retrospective study in which we examined the relationship between patient characteristics and prognosis in 161 stage IV CRC patients with indications for first-line systemic chemotherapy. Cox proportional-hazards models were used to compute hazard ratios (HR) for death, adjusted for clinical and pathological characteristics. RESULTS: Of the 161 patients recruited to the study, 83 had single-organ and 78 had multi-organ metastases. Median survival time was significantly shorter in patients with multi-organ metastases than in those with single-organ metastases (19.2 vs. 42.0 months, respectively; log-rank, P < 0.001). There was no significant difference in survival between patients with metastases in two versus three or more organs (log-rank; P = 0.368). According to univariate analysis, primary tumor sites in the left side of the colon and in the rectum, a pretreatment carcinoembryonic antigen concentration of >50 ng/mL, a well-/moderately differentiated tumor, and R0 resection of metastatic lesions were associated with better overall survival. According to multivariate analysis, left-sided location of the primary tumor [HR 0.414, 95 % confidence interval (CI) 0.216-0.815; P = 0.011] and R0 resection of metastatic lesions (HR 0.247, 95 % CI 0.04 0-0.834; P = 0.021) were independently associated with good prognosis. CONCLUSIONS: Our results indicate that the site of the primary tumor in the left side of the colon and in the rectum and R0 resection of metastatic lesions are predictors of a good prognosis in patients with stage IV CRC and multi-organ metastases.
Entities:
Keywords:
Colorectal cancer; Multi-organ metastasis; Prognostic factor; Stage IV
Authors: Jennifer M Weiss; Patrick R Pfau; Erin S O'Connor; Jonathan King; Noelle LoConte; Gregory Kennedy; Maureen A Smith Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Timothy J Price; Carol Beeke; Shahid Ullah; Robert Padbury; Guy Maddern; David Roder; Amanda R Townsend; James Moore; Amitesh Roy; Yoko Tomita; Christos Karapetis Journal: Cancer Date: 2014-11-06 Impact factor: 6.860
Authors: Leyo Ruo; Christina Gougoutas; Philip B Paty; Jose G Guillem; Alfred M Cohen; W Douglas Wong Journal: J Am Coll Surg Date: 2003-05 Impact factor: 6.113
Authors: Emily K Elizabeth McCracken; Gregory P Samsa; Deborah A Fisher; Norma E Farrow; Karenia Landa; Kevin N Shah; Dan G Blazer; Sabino Zani Journal: HPB (Oxford) Date: 2019-05-30 Impact factor: 3.647
Authors: Xu Chen; Zhi-Feng Lin; Wen-Jin Xi; Wei Wang; Dan Zhang; Fan Yang; Yu-Fang Li; Yi Huo; Tian-Ze Zhang; Yi-Hong Jiang; Wei-Wei Qin; An-Gang Yang; Tao Wang Journal: Cancer Med Date: 2019-02-21 Impact factor: 4.452
Authors: Sophia C Kamran; Jeffrey W Clark; Hui Zheng; Darrell R Borger; Lawrence S Blaszkowsky; Jill N Allen; Eunice L Kwak; Jennifer Y Wo; Aparna R Parikh; Ryan D Nipp; Janet E Murphy; Lipika Goyal; Andrew X Zhu; A John Iafrate; Ryan B Corcoran; David P Ryan; Theodore S Hong Journal: Cancer Med Date: 2018-05-17 Impact factor: 4.452